glp 1 gip dual agonist weight loss GLP-1 Vs Tirzepatide: Powerful Guide To Better Oral GLP-1-Based Therapeutics in the

Plaintiffs allege these companies failed to adequately warn about the risk of severe and sometimes permanent gastrointestinal complications

doi:10.3390/ph17020199 8

The total number of lawsuits against glucagon-like peptide-1 (GLP-1) drug manufacturers, such as Novo Nordisk, has grown to nearly 2,200, with more cases being filed monthly

The 2024 Lancet Commission on dementia prevention, intervention, and care updated its model to include 14 modifiable risk factors and estimated that roughly 45% of dementia cases may be delayed or reduced if those risks are addressed across the lifespan

The common and reported Wegovy side effects include nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose, or sore throat

Lean PMOS can still involve androgens, irregular cycles, thyroid issues, stress physiology, inflammation, or nutrient problems